Alpha Cognition Inc (ACOG) vs NervGen Pharma Corp. Common stock (NGEN)
A side-by-side comparison of Alpha Cognition Inc and NervGen Pharma Corp. Common stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACOG
Alpha Cognition Inc
$8.98HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NGEN
NervGen Pharma Corp. Common stock
$1.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ACOG vs NGEN
growth of $100 · dividends reinvested · last 1yACOG +52.5% (+52.5%/yr)NGEN -57.6% (-57.6%/yr)ACOG compounded faster over this window
ACOG NGEN
ACOG vs NGEN: by the numbers
- •NGEN is the larger company ($144M vs $139M market cap).
- •Both run net losses; NGEN's is the smaller (0.00% vs -153.61% net margin).
Metrics side by side
Valuation
| Metric | ACOG | NGEN |
|---|---|---|
| P/S ratio | 9.14 | N/A |
| P/B ratio | 2.63 | 11.81 |
Profitability
| Metric | ACOG | NGEN |
|---|---|---|
| Gross margin | 81.26% | 0.00% |
| Operating margin | -221.72% | 0.00% |
| Net margin | -153.61% | 0.00% |
| ROE | -44.26% | -397.38% |
| ROIC | -50.04% | -223.90% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.